论文部分内容阅读
银杏叶(ginkgo biloba leaf)制剂主要含黄酮苷和银杏苦酯,前者可清除氧自由基,后者可选择性拮抗血小板活化子(PAF)的有害作用,临床多用于治疗心脑血管疾病。者现将其作用机制、单独使用及联合用药治疗心脑疾病几方面作一综述。作用机制银杏叶制剂为银杏叶提取物,主要含黄酮苷和
Ginkgo biloba leaf (Ginkgo biloba leaf) preparations mainly contain flavonoid glycosides and ginkgo-bitic acid esters. The former can scavenge oxygen free radicals, and the latter can selectively antagonize the harmful effects of platelet activators (PAF), and are used clinically to treat cardiovascular and cerebrovascular diseases. The authors now review several aspects of their mechanisms of action, single use, and combination therapy for the treatment of cardio-cerebral diseases. Mechanism of action Ginkgo biloba leaf extract is Ginkgo biloba extract, which mainly contains flavonoid glycosides and